Apyx Medical Corporation Common Stock (NASDAQ: APYX) last traded at $2.59, up 9.75% on the session. The quote above updates while this page is open; the figures below are drawn from Apyx Medical Corporation Common Stock’s own filings and are restated only when a new one is published.
Apyx Medical Corporation Common Stock trades on NASDAQ under the ticker APYX. Its market capitalisation is $109.10 million.
Valuation measures for Apyx Medical Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $109.10M |
|---|---|
| Enterprise value | $131.47M |
| Price / sales | 1.87 |
| Price / book | 10.23 |
| Beta | 1.36 |
Trailing-twelve-month figures tagged in Apyx Medical Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $58.41M |
|---|---|
| Net income (TTM) | -$8.65M |
| EPS (TTM) | -$0.200 |
| Gross margin | 63.50% |
| Operating margin | -6.06% |
| Return on equity | -81.09% |
| Cash | $27.62M |
Range and volume for APYX over the past 52 weeks.
| 52-week high | $5.08 |
|---|---|
| 52-week low | $2.32 |
| Volume | 107.4K |
| Average volume | 127.3K |
| Previous close | $2.36 |
Invest a chosen dollar amount in Apyx Medical Corporation Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell APYX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.